AllisonAxtellMD

PubMed

• 79 citations
  Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
  Tina Raine-Bennett, Lue-Yen Tucker, Eve Zaritsky, Ramey D. Littell, Ted E. Palen, Romain Neugebauer, Allison E. Axtell, Peter M. Schultze, David W. Kronbach, Julia Emb...> ;Obstetrics and Gynecology. 2016 Jan 1
• 53 citations
  Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies.
  Kristine R. Penner, Nicole D. Fleming, Leah Barlavi, A. Axtell, Scott E. Lentz> ;American Journal of Obstetrics and Gynecology. 2015 Feb 1
• 6 citations
  Operative and anesthetic outcomes in endometrial cancer staging via three minimally invasive methods
  Nicole D. Fleming, A. Axtell, Scott E. Lentz> ;Journal of Robotic Surgery. 2012 Dec 1
• 179 citations
  Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment
  Giovanni Aletti, Eric L. Eisenhauer, Antonio Santillan, Allison E. Axtell, Giacomo Aletti, Christine H. Holschneider, Dennis S. Chi, Robert E. Bristow, William A. Cliby> ;Gynecologic Oncology. 2011 Jan 1
• 90 citations
  An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).
  Amanda N. Fader, David Starks, Paola A. Gehrig, Angeles Alvarez Secord, David M. O'Malley, Erin Tuller, Peter G. Rose, Laura J. Havrilesky, Kathleen N. Moore, Warner K...> ;Gynecologic Oncology. 2009 Nov 1
• Can primary recurrences in surgical stage I-II uterine papillary serous carcinoma (UPSC) patients be salvaged?
  Fader AN, Rose PG, Frasure H, Gehrig PA, Moore KN, Havrilesky LJ, Huh WK, Axtell AE, O'Malley DM, Zanotti KM> ;J. Clin. Oncol.. 2009-05-20
• 117 citations
  Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
  Amanda N. Fader, Richard D. Drake, David M. O'Malley, Heidi E. Gibbons, Warner K. Huh, Laura J. Havrilesky, Paola A. Gehrig, Erin Tuller, Allison E. Axtell, Kristine M...> ;Cancer. 2009 May 15
• 63 citations
  Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
  Amanda N. Fader, Christa Nagel, Allison E. Axtell, Kristine M. Zanotti, Joseph L. Kelley, Kathleen N. Moore, Angeles Alvarez Secord, Christine Walsh, Warner K. Huh, Pa...> ;Gynecologic Oncology. 2009 Mar 1
• "Debulk or not debulk?" An answer to an hamletic dilemma using a multi-institutional risk-adjusted model for evaluation of outcomes.
  Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, Chi DS, Bristow RE, Podratz KC, Cliby WA> ;J. Clin. Oncol.. 2008-05-20
• 55 citations
  Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer.
  Ritu Salani, Allison E. Axtell, Melissa A. Gerardi, Christine H. Holschneider, Robert E. Bristow> ;Gynecologic Oncology. 2008 Feb 1
• 28 citations
  Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.
  Kathleen N. Moore, Katherine M. Moxley, Amanda N. Fader, Allison E. Axtell, Rodney P. Rocconi, Lisa N. Abaid, Ilana Cass, Peter G. Rose, Charles A. Leath, Teresa Rutle...> ;Gynecologic Oncology. 2007 Dec 1
• 2 citations
  Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
  Allison E. Axtell, Joseph L. Kelley, Amanda N. Fader, Dilip Gupta, Benjamin M Schwartz, John T. Comerci, Yan Lin, Samuel Weiand, Holly H. Gallion, Amal Kanbour-Shakir> ;Gynecologic Oncology. 2007 Dec 1
• 175 citations
  Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer
  Allison E. Axtell, Margaret H. Lee, Robert E. Bristow, Sean C. Dowdy, William A. Cliby, Steven S. Raman, John P. Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz, Ilana ...> ;Journal of Clinical Oncology. 2007 Feb 1
• Join now to see all